- Home
- OMCC vs ICCC Comparison
OMCC vs ICCC Comparison
Compare OMCC & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCC
- ICCC
- Stock Information
- Founded
- OMCC 1985
- ICCC 1982
- Country
- OMCC United States
- ICCC United States
- Employees
- OMCC N/A
- ICCC N/A
- Industry
- OMCC
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- OMCC
- ICCC Health Care
- Exchange
- OMCC NYSE
- ICCC Nasdaq
- Market Cap
- OMCC 40.0M
- ICCC 45.9M
- IPO Year
- OMCC N/A
- ICCC 1987
- Fundamental
- Price
- OMCC $6.45
- ICCC $5.11
- Analyst Decision
- OMCC
- ICCC
- Analyst Count
- OMCC 0
- ICCC 0
- Target Price
- OMCC N/A
- ICCC N/A
- AVG Volume (30 Days)
- OMCC 6.9K
- ICCC 10.1K
- Earning Date
- OMCC 02-11-2025
- ICCC 02-25-2025
- Dividend Yield
- OMCC N/A
- ICCC N/A
- EPS Growth
- OMCC N/A
- ICCC N/A
- EPS
- OMCC N/A
- ICCC N/A
- Revenue
- OMCC $22,181,000.00
- ICCC $23,838,001.00
- Revenue This Year
- OMCC N/A
- ICCC N/A
- Revenue Next Year
- OMCC N/A
- ICCC N/A
- P/E Ratio
- OMCC N/A
- ICCC N/A
- Revenue Growth
- OMCC N/A
- ICCC 46.37
- 52 Week Low
- OMCC $5.29
- ICCC $3.34
- 52 Week High
- OMCC $7.55
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- OMCC N/A
- ICCC 52.70
- Support Level
- OMCC N/A
- ICCC $4.86
- Resistance Level
- OMCC N/A
- ICCC $5.50
- Average True Range (ATR)
- OMCC 0.00
- ICCC 0.36
- MACD
- OMCC 0.00
- ICCC -0.03
- Stochastic Oscillator
- OMCC 0.00
- ICCC 39.06
About OMCC OLD MARKET CAPITAL CORPORATION
Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.